Crescent Capital BDC, Inc. - Q2 2018 Filing Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended June 30, 2018. Crescent Capital BDC, Inc. is a closed-end, non-diversified management investment company organized as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The Company invests primarily in secured and unsecured debt and related equity securities of private U.S. middle-market companies. As of June 30, 2018, the Company had 10,341,086 shares of common stock outstanding.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2018 | Six Months Ended June 30, 2017 |
|---|---|---|
| Total Investment Income | $14,061,933 | $9,756,672 |
| Net Investment Income (after tax) | $6,884,243 | $4,193,868 |
| Net Increase in Net Assets from Operations | $5,116,935 | $6,506,854 |
| Net Asset Value (NAV) per Share | $19.93 | $20.41 |
| Total Investments (Fair Value) | $397,254,529 | $319,126,672 |
| Total Debt (Carrying Value) | $191,263,369 | $151,703,970 |
| Cash and Cash Equivalents | $9,211,691 | $7,364,125 |
| Asset Coverage Ratio | 2.07 to 1 | 2.12 to 1 |
Material Changes vs. Prior Period
- Portfolio Growth: Total investments at fair value increased by approximately $78.1 million (24.5%) compared to December 31, 2017, driven by new investment commitments of $153.6 million during the six-month period.
- Income Growth: Net investment income increased by 64.1% year-over-year, primarily due to the larger portfolio size. Interest income rose from $9.7 million to $13.9 million.
- Expense Increases: Total expenses increased to $7.2 million from $5.6 million. Interest and credit facility expenses rose to $3.6 million due to higher average debt balances ($159.3 million vs. $121.3 million) and increased interest rates (3.9% vs. 3.1%).
- Unrealized Losses: The Company recorded a net unrealized depreciation of $1.56 million for the six months ended June 30, 2018, compared to a net unrealized appreciation of $2.58 million in the prior year period. This was largely driven by a $1.41 million decrease in the fair value of Senior Secured Second Lien investments.
- Fee Waivers: The Advisor waived income incentive fees effective April 1, 2018, resulting in $0 incentive fees for the quarter ended June 30, 2018, compared to $392,977 in the prior year quarter.
Guidance, Outlook, and Risks
- Capital Commitments: The Company has $185.7 million in remaining unfunded capital commitments from investors as of June 30, 2018.
- Debt Facilities: The Company amended its Revolving Credit Facility II on June 28, 2018, increasing the limit to $85 million and extending the maturity to June 29, 2019. Total committed debt facilities stand at $210 million.
- Non-Accrual Status: As of June 30, 2018, one investment (Professional Physical Therapy) was placed on non-accrual status, representing 1.7% of total investments at fair value. No loans were on non-accrual status as of December 31, 2017.
- Forward-Looking Risks: The filing highlights risks including potential fluctuations in quarterly results, economic recessions, adverse credit market developments, and the impact of interest rate changes on net investment income. The Company notes that 92.9% of its debt portfolio bears floating interest rates.
- Subsequent Events: The Company issued common shares and received gross proceeds of approximately $25 million subsequent to June 30, 2018.
Investor Verification Checklist
- Fee Waiver Impact: Verify the duration and conditions of the income incentive fee waiver agreed to by the Advisor in exchange for the Commitment Period extension.
- Non-Accrual Exposure: Review the specific details of the Professional Physical Therapy investment placed on non-accrual status and its potential impact on future cash flows.
- Debt Covenants: Confirm continued compliance with the 2.0 to 1 asset coverage ratio requirement under the 1940 Act, especially given the increased leverage.
- Valuation Methodology: Note that $332.9 million (83.8%) of the portfolio is classified as Level 3 (unobservable inputs), requiring significant management judgment in fair value determination.
- Capital Drawdowns: Monitor the utilization of the $185.7 million in unfunded capital commitments to assess future dilution or growth potential.